This market analysis segments the global cephalosporin drugs market by generation of cephalosporin (first generation, second generation, third generation, fourth generation, and fifth generation), by route of administration (injection and oral), and by geography (APAC, EMEA, and the Americas). Leading vendors analysed in this report are Allergan, Astellas, Bristol-Myers Squibb, GSK, Merck, Pfizer, Sandoz, and Teva.
Technavio’s market research analysts estimate the global cephalosporin drugs market to grow at a CAGR of around 3% between 2015 and 2019. The APAC dominates the global market for cephalosporin drugs, occupying around 58% of the total market share. The augmented demand for a better healthcare infrastructure in this region is expected to drive market growth in APAC during the next four years.
The new market research report from Technavio provides a breakdown and analysis of the cephalosporin drugs segments by route of drug delivery and categories.
“Increased presence for combination therapies for easy and efficient treatment is one of the latest trends in this market. Combination drugs are increasingly receiving approval owing to their effectiveness compared to monotherapies. Of late, the combination of cephalosporins with beta-lactamase inhibitors is commonly used for the treatment of infections. Moreover, the recent approvals of drugs like Zerbaxa and Avycaz by the US FDA have boosted the use of combination therapies in this market,” says Imran Mushtaq, Lead Analyst, Pharma, Technavio Research.
This market study estimates the injection segment to be the most preferred route of drug administration as it results in rapid drug delivery. Its usefulness in replacing fluids, delivering chemotherapeutic drugs, and performing blood transfusions results in its high popularity during the forecast period.
Cephalosporins are bactericidal antibiotics, which prevent the spread of Gram-positive and Gram-negative bacteria, through hindering the synthesis of the bacterial cell wall. They are broad-spectrum antibiotics and are used under strict regulations. Cephalosporins are grouped into five generations depending on their antimicrobial properties, with each generation showing a significant increase in terms of Gram-negative antimicrobial property.
The key vendors in the global cephalosporin drugs market are Allergan, Astellas, Bristol-Myers Squibb, GSK, Merck, Pfizer, Sandoz, and Teva. This market is characterized by the presence of many large and small vendors who continually compete with each other to gain maximum traction in this market. Companies which can manufacture and market the highly efficient and safe cephalosporin drugs are expected to gain a competitive edge in this market.
A more detailed analysis is available in the Technavio report, Global Cephalosporin Drugs Market 2015-2019.
https://www.technavio.com/%3Cp%3E%3Cstrong%3EWe%20can%20customize%20repor…
